Publicaciones en colaboración con investigadores/as de Stanford University (16)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Ageing-associated small RNA cargo of extracellular vesicles

    RNA Biology, Vol. 20, Núm. 1, pp. 482-494

  3. Assessing the usefulness of randomised trials in obstetrics and gynaecology

    BJOG: An International Journal of Obstetrics and Gynaecology

  4. Association of Early Pregnancy Perfluoroalkyl and Polyfluoroalkyl Substance Exposure With Birth Outcomes

    JAMA Network Open, Vol. 6, Núm. 5

  5. Effects of an Exercise Program on Cardiometabolic and Mental Health in Children with Overweight or Obesity: A Secondary Analysis of a Randomized Clinical Trial

    JAMA Network Open, Vol. 6, Núm. 7, pp. E2324839

  6. Epigenetic Regulation of Driver Genes in Testicular Tumorigenesis

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  7. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  8. GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors

    American Journal of Psychiatry

  9. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

2022

  1. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

    Biological psychiatry, Vol. 91, Núm. 3, pp. 313-327

  2. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

2021

  1. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

  2. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  3. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

    The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107